Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma

Biochemical and Biophysical Research Communications

Volumn 445, Issue 3, 2014, Pages 661-666

  Ueda, Masashi ^a,b,d   Fukushima, Takahiro ^b   Ogawa, Kei ^b   Kimura, Hiroyuki ^b   Ono, Masahiro ^b   Yamaguchi, Takashi ^c   Ikehara, Yuzuru ^c   Saji, Hideo ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Nuclear medical imaging; Pancreatic ductal adenocarcinoma; Small animal SPECT CT; v 6 Integrin

Indexed keywords

ALPHAVBETA6 INTEGRIN; IFMDV2 I 125; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING ASSAY; CANCER DIAGNOSIS; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIOACTIVITY; RADIOIODINATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGOUTI PACA; ANIMALIA; MUS;

NUCLEAR MEDICAL IMAGING; PANCREATIC DUCTAL ADENOCARCINOMA; SMALL ANIMAL SPECT/CT; ΑVΒ6 INTEGRIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; HUMANS; INTEGRINS; IODINE RADIOISOTOPES; MICE; MOLECULAR SEQUENCE DATA; PANCREAS; PANCREATIC NEOPLASMS; PEPTIDES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84896319083     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.086     Document Type: Article

References (28)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin. 2012, 62:10-29.
2. Stan S.D., Singh S.V., Brand R.E. Chemoprevention strategies for pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:347-356.
3. Hazelbag S., Kenter G.G., Gorter A., et al. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J. Pathol. 2007, 212:316-324.
4. Zhang Z.Y., Xu K.S., Wang J.S., et al. Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma. Clin. Oncol. 2008, 20:61-66.
5. Sipos B., Hahn D., Carceller A., et al. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology 2004, 45:226-236.
6. Burman A., Clark S., Abrescia N.G., et al. Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. J. Virol. 2006, 80:9798-9810.
7. 18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography. Cancer Res. 2007, 67:7833-7840.
8. Elayadi A.N., Samli K.N., Prudkin L., et al. A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer. Cancer Res. 2007, 67:5889-5895.
9. Pameijer C.R., Navanjo A., Meechoovet B., et al. Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor. Cancer Gene Ther. 2007, 14:91-97.
10. Hsiao J.R., Chang Y., Chen Y.L., et al. Cyclic alphavbeta6-targeting peptide selected from biopanning with clinical potential for head and neck squamous cell carcinoma. Head Neck. 2010, 32:160-172.
11. 64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide. Mol. Imaging 2009, 8:111-121.
12. 18F]fluorine by copper-free, strain-promoted click chemistry. Nucl. Med. Biol. 2013, 40:233-239.
13. Saha A., Ellison D., Thomas G.J., et al. High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6. J. Pathol. 2010, 222:52-63.
14. Ueda M., Ogawa K., Miyano A., et al. Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors. Mol. Imaging Biol. 2013, 15:713-721.
15. Harada N., Kimura H., Ono M., et al. Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging. J. Med. Chem. 2013, 56:7890-7901.
16. Kondo N., Temma T., Shimizu Y., et al. Miniaturized antibodies for imaging membrane type-1 matrix metalloproteinase in cancers. Cancer Sci. 2013, 104:495-501.
17. Duncan J.R., Welch M.J. Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. J. Nucl. Med. 1993, 34:1728-1738.
18. 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts. Cancer Biother. Radiopharm. 1998, 13:133-139.
19. Hausner S.H., Abbey C.K., Bold R.J., et al. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res. 2009, 69:5843-5850.
20. 177Lu-DOTA-bombesin analogues. EJNMMI Res. 2012, 2:24.
21. Gaertner F.C., Kessler H., Wester H.J., et al. Radiolabelled RGD peptides for imaging and therapy. Eur. J. Nucl. Med. Mol. Imaging 2012, 39(Suppl. 1):S126-S138.
22. 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin alphavbeta3 targeting using single photon emission computed tomography and optical imaging. Cancer Sci. 2012, 103:1105-1110.
23. Zheleznyak A., Wadas T.J., Sherman C.D., et al. Integrin alpha(v)beta(3) as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. Mol. Imaging Biol. 2012, 14:500-508.
24. 111In-DOTA-c(RGDfK) to detect early pancreatic cancer in a hamster pancreatic carcinogenesis model. J. Nucl. Med. 2012, 53:765-771.
25. Hosotani R., Kawaguchi M., Masui T., et al. Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. Pancreas 2002, 25:e30-e35.
26. Van den Broeck A., Vankelecom H., Van Eijsden R., et al. Molecular markers associated with outcome and metastasis in human pancreatic cancer. J. Exp. Clin. Cancer Res. 2012, 31:68.
27. Kraft S., Diefenbach B., Mehta R., et al. Definition of an unexpected ligand recognition motif for alphav beta6 integrin. J. Biol. Chem. 1999, 274:1979-1985.
28. Nishigori K., Temma T., Yoda K., et al. Radioiodinated peptide probe for selective detection of oxidized low density lipoprotein in atherosclerotic plaques. Nucl. Med. Biol. 2013, 40:97-103.